Safety, Tolerability, and Profile of Action of Drug in the Body of NN9535 in Healthy Male Japanese and Caucasian Subjects

0.1 mg once weekly, s.c. injection

0.2 mg once weekly, s.c. injection

0.4 mg once weekly, s.c. injection

0.4 mg once weekly for 1 week, 0.8 mg once weekly for 7 weeks, s.c. injection

0.4 mg once weekly for 1 week, 0.8 mg once weekly for 1 week, 1.2 mg once weekly for 6 weeks, s.c. injection

0.1 mg once weekly, s.c. injection

0.2 mg once weekly, s.c. injection

0.4 mg once weekly, s.c. injection

0.4 mg once weekly for 1 week, 0.8 mg once weekly for 7 weeks, s.c. injection

0.4 mg once weekly for 1 week, 0.8 mg once weekly for 1 week, followed by 1.2 mg once weekly injections for 6 weeks, s.c. injection